Business News • PR NewsWire • ImmusanT's Epitope-Specific Immunotherapy for Celiac Disease Informs the Potential of Vaccines Against Other Autoimmune Diseases

ImmusanT's Epitope-Specific Immunotherapy for Celiac Disease Informs the Potential of Vaccines Against Other Autoimmune Diseases

ImmusanT's Epitope-Specific Immunotherapy for Celiac Disease Informs the Potential of Vaccines Against Other Autoimmune Diseases

CAMBRIDGE, Mass., April 19, 2013 /PRNewswire/ -- In autoimmune disorders such as celiac disease and Type 1 diabetes, the body's immune system attacks its own cells. Current treatments for many autoimmune disorders are limited to immunosuppressants, but researchers are exploring the...

View More : http://www.prnewswire.com/news-releases/immusants-epitope-specific-immunotherapy-for-celiac-disease-informs-the-potentia...

Releted News by prnewswire

Northrop Grumman Launches CUTLASS, Next Generation Unmanned Ground Vehicle

IG propose à ses clients de négocier sur Bitcoin

NEOSA Announces Best of Tech Awards Winners

ImmusanT's Epitope-Specific Immunotherapy for Celiac Disease Informs the Potential of Vaccines Against Other Autoimmune Diseases

Southwest Airlines Announces New Chief Technology Officer